에 대한 최신 뉴스 Zenith Energy (OTC:ZENAF) 주식

Zenith Energy Ltd is an international independent oil and gas company with production, exploration, and development assets in the Republic of the Congo, Italy, and Tunisia. The company's strategic focus is the development of revenue-generating oil production assets, as well as low-risk exploration activities in assets with existing production. Its segments are Italy, Tunisia, and Others.

ZENITH ENERGY LTD NEW by Zenith Energy Ltd.

Zenith Energy Ltd

Zuanic &amp; Associates hosted an online panel, &#8220;The Hemp Derivatives Advocates&#8221; that brought together key players in the hemp industry to discuss the regulatory challenges around <a href="https://www.benzinga.com/markets/cannabis/24/09/40956859/hemp-derived-products-like-delta-8-thc-are-here-to-stay-says-analyst">hemp-derived products</a>.
In the midst of this national discussion, Christopher Lackner, president of the Hemp Beverage Alliance, JD McCormick, chairman of the American Healthy Alternatives Association, and Jonathan Miller, general counsel of the U.S. Hemp Roundtable, advocated a united front to face growing hemp restrictions. The <a href="https://www.benzinga.com/topic/florida-cannabis">situation</a> in Florida got particular attention.
McCormick emphasized the impressive growth of hemp-derived products. Citing a sales report from Whitney Economics, he estimated the industry in the zone of $2.8 billion dollars a year. 
&#8220;Many hemp retailers in states like Florida, Georgia, Tennessee, North and South Carolina are doing hundreds of thousands of dollars in sales at the retail level a month, many millions of dollars a year,&#8221; he said.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/39820619/strategy-shift-in-the-works-are-cannabis-giants-getting-into-the-hemp-derived-thc-market">Strategy Shift In The Works? Are Cannabis Giants Getting Into The Hemp Derived-THC Market?</a>
<h3 class="wp-block-heading">Proliferation Of THC Beverages </h3>
Lackner spoke about the potential of the <a href="https://www.benzinga.com/markets/cannabis/24/08/40509701/hemp-derived-thc-beverages-navigating-regulatory-uncertainty-in-a-potential-13-5b-market">hemp beverage market</a>, which continues to gain momentum despite its relatively small size.
&#8220;There isn&#8217;t a Budweiser or a PepsiCo out there quite yet,&#8221; Lackner said, &#8220;but we are seeing a lot of national and international brands really beginning to eke their way out.&#8221; He referenced emerging brands such as Rebel Rabbit, Cycling Frog and Mary Jones Soda, predicting they&#8217;ll soon be common names in stores across the country.
He added that hemp-derived THC beverages are finding their way <a href="https://www.benzinga.com/markets/cannabis/24/08/40225540/summer-sizzles-with-thc-infused-beverages-market-report-reveals-top-selling-weed-drinks-in-u-s">into new markets</a>. &#8220;New liquor stores, new chains…they&#8217;re coming for THC beverages.&#8221; he said, emphasizing the category&#8217;s potential to revolutionize the adult beverage sector. 
<h3 class="wp-block-heading">Can Hemp Thrive In Legal Cannabis Markets?</h3>
&#8220;Absolutely not,&#8221; said McCormick when asked if cannabis prohibition was beneficial to hemp derivatives products.
&#8220;Probably the best example of this is the state of Illinois. Some of the largest recreational marijuana operators in the country exist in Chicago, Illinois. You also have thousands and thousands of hemp retailers, and distributors, some of the largest distributors in the United States in the hemp space are based there," he said.
Despite its growth, the hemp industry is grappling with regulatory threats in several states.
Miller addressed the situation in <a href="https://www.benzinga.com/markets/cannabis/24/08/40323184/missouri-governors-thc-ban-threatens-9-000-retailers-statewide-amid-nationwide-clampdown-on-hemp">Missouri</a> and <a href="https://www.benzinga.com/markets/cannabis/24/09/41012794/gov-newsoms-hemp-ban-goes-into-effect-consequences-for-industry-investors-patients">California</a> where authorities are restricting or banning hemp products. He introduced the idea of a coalition of big cannabis players being behind some of these hemp bans.
Florida&#8217;s Governor Ron DeSantis recently <a href="https://www.benzinga.com/markets/cannabis/24/06/39243424/desantis-vetoes-bill-that-would-regulate-intoxicating-hemp-in-lifeline-to-industry-as-he-bashes-">vetoed</a> legislation that would have severely restricted hemp activity. Hemp groups are actively <a href="https://www.benzinga.com/markets/cannabis/24/07/39760907/ron-desantis-floridas-gop-and-hemp-industry-pile-on-to-defeat-marijuana-legalization">opposing</a> a cannabis legalization initiative, knows as Amendment 3.
McCormick linked Amendment 3 to what he called a cannabis monopoly and criticized the market domination of large cannabis companies, arguing that they use their influence to rig the market at the expense of smaller hemp operators.
&#8220;There are dozens upon dozens of marijuana lobbyists in the state of Florida. And so if you think that the limited licenses and monopolistic privileges of some of these companies&#8230;if you think that Tiger is going to change its stripes after they get recreational marijuana, I would argue that the opposite is true,&#8221; McCormick said. &#8220;They&#8217;re going to say, okay, we&#8217;ve got constitutional protection. Now let&#8217;s double and triple the lobbying efforts. Let&#8217;s solidify our monopolistic goals here.&#8221;
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">A Call For Thoughtful Hemp Regulation</h3>
Looking ahead, the panelists agreed on the need for clear and fair federal regulation. 
They pointed to Senator Ron Wyden's <a href="https://www.benzinga.com/markets/cannabis/24/09/41069354/synthetic-cannabinoids-could-be-federally-banned-under-new-senate-bill-to-regulate-hemp-derived-">Cannabinoid Safety and Regulation Act </a>as a potential guide for managing hemp-derived products.
&#8220;It would ensure that products are properly, appropriately age-gated…and provide transparency when it comes to what&#8217;s in the product,&#8221; Miller explained.
&#8220;That&#8217;s the blueprint,&#8221; he added.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/09/40698576/navigating-hemp-vs-cannabis-debate-one-agenda-for-all-us-cannabis-councils-david-culver-weighs-i">Navigating Hemp Vs. Cannabis Debate: One Agenda For All? US Cannabis Council&#8217;s David Culver Weighs In</a></li>
</ul>
Cover: AI generated image

Cannabis

Government

News

Regulations

Politics

Exclusives

Markets

TCNNF

Experts Link Florida's Cannabis Legalization Effort To 'Monopolistic Goals,' Offer A Blueprint For Hemp Regulation

Barclays analyst Saket Kalia maintains CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Overweight and raises the price target from $315 to $330.

Price Target

Analyst Ratings

CYBR

Barclays Maintains Overweight on CyberArk Software, Raises Price Target to $330

WIIM

GANX

Gain Therapeutics shares are trading higher after the company announced the presentation of new evidence supporting the disease-modifying activity of Gt-02287 in preclinical animal models of both GBA-1 and idiopathic Parkinson's disease.

BMBL

GOOG

GOOGL

HOOD

MTCH

RBLX

SPOT

U.S. Judge Orders Google To Open Up App Store To More Competition

Barclays analyst Benjamin Budish maintains Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) with a Equal-Weight and raises the price target from $141 to $155.

Barclays Maintains Equal-Weight on Blackstone, Raises Price Target to $155

LGCY

Legacy Education shares are trading higher after the company reported a year-over-year increase in Q4 financial results.

Barclays analyst Benjamin Budish maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Overweight and raises the price target from $990 to $1010.

Barclays Maintains Overweight on BlackRock, Raises Price Target to $1010

FMC Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) stock looks promising at the moment. It benefits from efforts to expand its product portfolio through new product launches and its restructuring actions.
Let&#39;s see what makes FMC stock a compelling investment option at the moment.
<h2>FMC Stock Outperforms Industry</h2>
FMC has outperformed the industry it belongs to over the past three months. The company&#39;s shares have gained 13.8% compared with a 7.7% rise of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c7/80480.jpg?v=1918707670" />
Image Source: Zacks Investment Research
<h2>FMC&#39;s Valuation Looks Attractive</h2>
FMC&#39;s attractive valuation should lure investors seeking value. The stock is currently trading at a forward 12-month earnings multiple of 14.52X, representing a roughly 12.4% discount when stacked up with the industry average of 16.58X. FMC also has a Value Score of B.
<h2>FMC&#39;s Earnings Estimates Going Up</h2>
Earnings estimates for FMC have been going up over the past 60 days. The Zacks Consensus Estimate for 2024 has increased by 0.6%. The consensus estimate for 2025 has also been revised 3.5% upward over the same time frame.
<h2>New Products, Restructuring Actions Aid FMC Stock</h2>
FMC remains focused on strengthening its product portfolio. It is investing in technologies as well as new product launches to enhance value to the farmers. New products launched in Europe, North America and Asia are gaining significant traction. Product introductions are expected to support the company&#39;s results this year.
FMC generated $590 million in sales in 2023 from new products launched in the past five years. It expects revenues from new products to grow by roughly $200 million in 2024. It expects a significant amount of volume growth to come from new products in the second half of 2024. FMC is seeing strong gains in new products including Coragen eVo and Premio Star insecticides and the Onsuva fungicide in Latin America.
The acquisition of BioPhero ApS, a Denmark-based pheromone research and production company, also adds biologically produced state-of-the-art pheromone insect control technology to the company&#39;s product portfolio and R&amp;D pipeline, highlighting FMC&#39;s role as a leader in delivering innovative and sustainable crop protection solutions.
The company is also expected to benefit from reduced input costs, favorable product mix and its cost-control actions. It benefited from favorable input costs in the second quarter of 2024. FMC is also making progress with its global restructuring and cost-reduction program. It sees benefits from restructuring to contribute $75-$100 million to full-year 2024 adjusted EBITDA, net of inflation.
<div class="chart_embed">
<h3>FMC Corporation Price and Consensus</h3>
<img alt="FMC Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/17/1728291628.png" style="height:265px; width:576px" title="" />
FMC Corporation price-consensus-chart | FMC Corporation Quote
</div>
<h2>FMC&#39;s Zacks Rank &amp; Other Key Picks</h2>
FMC currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks in the Basic Materials space are IAMGOLD Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iag#NYSE">IAG</a>), Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>) and Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>). While IAMGOLD sports a Zacks Rank #1 (Strong Buy), Cabot and Axalta Coating carry a Zacks Rank #2.
The Zacks Consensus Estimate for IAMGOLD&#39;s current-year earnings has increased by 45.4% in the past 60 days. IAG beat the consensus estimate in each of the last four quarters with the average surprise being 200%. Its shares have shot up roughly 132% in the past year.
The consensus estimate for Cabot&#39;s current fiscal year earnings is pegged at $7.07 per share, indicating a year-over-year rise of 31.4%. The consensus estimates for CBT&#39;s current-year earnings has increased by 4.3% in the past 60 days. The company&#39;s shares have rallied roughly 61% in the past year.
The Zacks Consensus Estimate for Axalta Coating&#39;s current year earnings is pegged at $2.07, indicating a rise of 31.9% from year-ago levels. The Zacks Consensus Estimate for AXTA&#39;s current year earnings has increased 2.5% in the past 60 days. The stock has gained around 32% in the past year.
<a href="https://www.zacks.com/stock/news/2346902/here-s-why-you-should-add-fmc-stock-to-your-portfolio-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2346902">To read this article on Zacks.com click here.</a>

Earnings

Earnings Beats

Mid Cap

Penny Stocks

Trading Ideas

AXTA

Here's Why You Should Add FMC Stock to Your Portfolio Now

Barclays analyst Benjamin Budish maintains Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) with a Overweight and raises the price target from $155 to $174.

ARES

Barclays Maintains Overweight on Ares Management, Raises Price Target to $174

Barclays analyst Benjamin Budish maintains Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) with a Overweight and raises the price target from $128 to $148.

Barclays Maintains Overweight on Apollo Global Management, Raises Price Target to $148

Barclays analyst Carter Gould maintains Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) with a Equal-Weight and raises the price target from $300 to $315.

AMGN

Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $315

DUOT

Duos Technologies shares are trading higher after the company announced a partnership with Acuu-Tech to deploy its Edge AI data centers across the US.

Barclays analyst Saket Kalia maintains Alarm.com Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRM#NASDAQ">ALRM</a>) with a Equal-Weight and lowers the price target from $72 to $60.

ALRM

Barclays Maintains Equal-Weight on Alarm.com Holdings, Lowers Price Target to $60

Barclays analyst Carter Gould maintains AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) with a Overweight and raises the price target from $200 to $212.

ABBV

Barclays Maintains Overweight on AbbVie, Raises Price Target to $212

<a href="https://asia.nikkei.com/Spotlight/Cybersecurity/Japan-seeks-homegrown-unbreakable-quantum-encryption-by-2030" title="https://asia.nikkei.com/Spotlight/Cybersecurity/Japan-seeks-homegrown-unbreakable-quantum-encryption-by-2030">https://asia.nikkei.com/Spotlight/Cybersecurity/Japan-seeks-homegrown-unbreakable-quantum-encryption-by-2030</a>

Macro Notification

General

CHKP

CRWD

INTC

NVDA

PANW

'Japan seeks homegrown 'unbreakable' quantum encryption by 2030' - Nikkei

BCLI

Brainstorm Cell Therapeutics shares are trading higher after the company announced its CEO will discuss its Phase 3b ALS trial at the Maxim Healthcare virtual summit.

Rent the Runway (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rent#NASDAQ">RENT</a>) is a micro-cap stock whose price target was recently updated by Jefferies. This signals that the name could have nearly triple-bagger upside. According to MT Newswires, analysts at Jefferies updated their price target for the firm on Sept. 6. That target now sits at $26 per share, while the company trades at $9.31 per share. This implies that the analyst believes shares could rise 180% from their current level.
To understand this lofty target, I&#39;ll examine the&nbsp;consumer discretionary firm&#39;s operations, competitors, and financial situation.
<h2>Rent the Runway Aims to Offer Customers an &quot;Unlimited Closet&quot;</h2>
Rent the Runway (RTR) is a fashion company with a unique business model. The company is a platform where customers can rent pieces of clothing. It specifically caters to women, allowing them to rent high-priced designer garments. This allows its customers to access these garments for a much lower price than having to buy them.
This opens up the world of designer clothing to many more people, allowing many users to split the cost of those garments. RTR points out that its average customer wears clothes worth 25 times more than what they pay in subscription fees for the service annually. The company aims to provide its customers with an &quot;unlimited closet&quot; as they can swap out their garments for other ones whenever they like. It generates revenue mostly through subscriptions to this service, which cost between $94 and $235 per month.
<h2>RTR: Improving Profitability Big Time, But a Massive Competitor Is Stealing Growth</h2>
Looking at the financials of Rent the Runway, it is a mixed bag. On the positive side, the company is becoming more profitable. The company has increased its gross margin by nearly 600 basis points since fiscal year 2021. Last quarter, its adjusted EBITDA margin was over 17%. That&#39;s a 700+ basis point increase from last year.
Additionally, its free cash flow has increased massively. The number through the first six months of 2024 sits at -$6 million, compared to -$30 million in the same 2023 period. The company says it expects to break even on cash flow in 2024.
Looking at cash flow is particularly important for a firm like RTR over net income, as product depreciation expense equals 21% of its revenue. Depreciation is a non-cash expense; it is an accounting expense. So, this isn&#39;t cash that the company is spending. The company deducts it from its net income but not its cash flow.
The ultimate goal of a business is to generate positive cash rather than a positive accounting profit, i.e., net income. A company&#39;s cash flow paints a better picture of its financial situation.
However, a big problem for RTR is the fact that its active subscribers are declining. The figure fell 3% year over year last quarter. Meanwhile, competitors like Nuuly saw active subscribers grow by 55% last quarter. Nuuly&#39;s average active subscribers now sit at over 250,000, nearly double that of RTR. This is despite the fact that the company has only been active for around five years versus 15 years for RTR.
This difference signals growth in this industry, but it&#39;s not going to RTR. This means that RTR&#39;s offerings are likely viewed as inferior to Nuuly&#39;s and do not give customers the items they want.
Nuuly, owned by the massive firm Urban Outfitters (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/urbn#NASDAQ">URBN</a>), enjoys a big advantage in acquiring a variety of clothing to offer customers. This is very difficult for the small RTR to compete with. This difference in being able to offer a wider variety of options is a likely source of Nuuly&#39;s superior growth. Nuuly also has a lower price point, offering more casual clothing that can appeal to a wider audience.
<h2>RTR&#39;s Rock-Bottom Valuation Sparks Wall Street Interest</h2>
Despite its issues, it&#39;s hard to dismiss RTR&#39;s extremely low valuation. It is trading at nearly one-tenth of its projected sales over the next twelve months. This is assuredly a big reason why some Wall Street analysts place such large price targets on the firm.
Its increasing profitability is great to see, but it likely needs to see growth reaccelerate before the market will give it any credit. If it can&#39;t, this indicates that RTR&#39;s offerings to customers have fundamental issues, and the company can&#39;t expect to succeed long term. Still, its valuation makes it an interesting name to watch if it can find a way to start growing again.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/analysts-see-180-upside-for-rent-the-runway-should-you-buy/">Analysts See 180% Upside for Rent the Runway: Should You Buy?</a>&quot; first appeared on MarketBeat.

Offerings

Retail Sales

Small Cap

RENT

URBN

Analysts See 180% Upside for Rent the Runway: Should You Buy?

GOVX

SNGX

HHS Says CDC To Issue Level 3 Travel Health Notice For Rwanda On Oct 7; Rwanda Has Reported 49 Cases And 12 Deaths From Marburg Virus As Of Oct 6; CDC To Begin Public Health Entry Screening For Travelers Entering US From Rwanda Starting Week Of Oct 14; Level 3 Notice Recommends Reconsideration Of Nonessential Travel To Rwanda

MicroCloud Hologram's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NYSE">HOLO</a>) short percent of float has risen 63.37% since its last report. The company recently reported that it has 5.82 million shares sold short, which is 7.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>MicroCloud Hologram Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728324923_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MicroCloud Hologram has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing MicroCloud Hologram's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, MicroCloud Hologram's peer group average for short interest as a percentage of float is 3.93%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

How Is The Market Feeling About MicroCloud Hologram?

Heico's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>) short percent of float has fallen 9.17% since its last report. The company recently reported that it has 1.92 million shares sold short, which is 4.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.17 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Heico Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728324918_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Heico has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Heico's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Heico's peer group average for short interest as a percentage of float is 2.75%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Comments

Zenith Energy

뉴스

에 대한 최신 뉴스 Zenith Energy (OTC:ZENAF) 주식

뉴스

파트너 / 기고자

벤징가 글로벌